PHASE-I STUDY OF ANTILIPOPOLYSACCHARIDE HUMAN MONOCLONAL-ANTIBODY MAB-T88

被引：12

作者：

DAIFUKU, R ^{[1
]}

HAENFTLING, K ^{[1
]}

YOUNG, J ^{[1
]}

GROVES, ES ^{[1
]}

TURRELL, C ^{[1
]}

MEYERS, FJ ^{[1
]}

机构：

[1] CHIRON CORP,1400 53RD ST,EMERYVILLE,CA 94608

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1992年 / 36卷 / 10期

关键词：

D O I：

10.1128/AAC.36.10.2349

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Monoclonal antibody MAB-T88 is a human monoclonal immunoglobulin M antibody directed at the lipopolysaccharide of gram-negative bacteria. In this study, nine patients who were expected to become neutropenic from antineoplastic chemotherapy received an infusion of MAB-T88, three patients at each of three doses: 1, 4, and 8 mg/kg of body weight. MAB-T88 was shown to be safe, with an effective half-life in plasma of 25.4 h, and no patient developed immunoglobulin G antibody to MAB-T88.

引用

收藏

页码：2349 / 2351

页数：3

相关论文

共 50 条

[21] ANTIBODY LOCALIZATION IN HUMAN RENAL-CELL CARCINOMA - A PHASE-I STUDY OF MONOCLONAL ANTIBODY-G250 [J].

OOSTERWIJK, E ;

BANDER, NH ;

DIVGI, CR ;

WELT, S ;

WAKKA, JC ;

FINN, RD ;

CARSWELL, EA ;

LARSON, SM ;

WARNAAR, SO ;

FLEUREN, GJ ;

OETTGEN, HF ;

OLD, LJ .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :738-750

[22] ANTIBODY LOCALIZATION AND PHARMACOKINETICS IN PHASE I MONOCLONAL-ANTIBODY TRIALS [J].

SCHROFF, RW ;

MORGAN, AC ;

WOODHOUSE, CS ;

FARRELL, MM ;

KLEIN, RK ;

OLDHAM, RK ;

FOON, KA .

PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR) :236-236

[23] PHASE-I RADIOIMMUNOTHERAPY (RAIT) WITH I-131-LABELED MN-14F(AB)2, A CARCINOEMBRYONIC ANTIGEN (CEA)-SPECIFIC, MURINE MONOCLONAL-ANTIBODY (MAB) [J].

SHARKEY, RM ;

IZON, D ;

GASCON, P ;

LEVINE, GM ;

VAGG, R ;

AHMAD, M ;

PAWLYK, D ;

SIEGEL, JA ;

HANSEN, HJ ;

SWAYNE, LC ;

GOLDENBERG, DM .

JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) :P53-P53

[24] ANTI-T CELL MONOCLONAL-ANTIBODY (MAB) THERAPY IN THE NOD MOUSE [J].

SHIZURU, JA ;

TAYLOREDWARDS, C ;

BANKS, BA ;

FATHMAN, CG .

DIABETES, 1988, 37 (05) :A9-A9

[25] A MONOCLONAL-ANTIBODY (MAB) THAT INHIBITS PROLIFERATION OF HUMAN-CELLS BY BLOCKING CYTOKINESIS [J].

VAICKUS, L ;

LEVY, R .

FEDERATION PROCEEDINGS, 1985, 44 (04) :1178-1178

[26] MULTIPLE INFUSION OF ANTI-EGFR MONOCLONAL-ANTIBODY (EMD 55900) IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS - A PHASE-I STUDY [J].

POISSON, M ;

VEGA, F ;

ALBUQUERQUE, L ;

MONJOUR, A ;

CHEN, QM ;

DELATTRE, JY .

NEUROLOGY, 1993, 43 (04) :A247-A248

[27] ANTI-MOUSE RESPONSES TO MONOCLONAL-ANTIBODY (MAB) THERAPY IN HUMAN PATIENTS [J].

SMITH, LM ;

UNGER, M ;

BARTHOLOMEW, R .

JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) :942-942

[28] PHASE-I TRIAL OF MURINE MONOCLONAL-ANTIBODY (MAB) L6 DIRECTED AGAINST A SURFACE-ANTIGEN EXPRESSED IN HUMAN-LUNG - COLON - OVARY AND BREAST-CANCER [J].

GOODMAN, GE ;

HELLSTROM, I ;

BRODZINSKY, L ;

HUMMEL, D ;

BERMAN, J ;

SMALDONE, L ;

HELLSTROM, KE .

PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 :185-185

[29] RADIOIMMUNODETECTION (RID) OF HUMAN SOLID TUMOR XENOGRAFTS BY 125I-TURP-73 MONOCLONAL-ANTIBODY (MAB) [J].

COX, AD ;

WRIGHT, GL ;

STARLING, JJ .

FEDERATION PROCEEDINGS, 1987, 46 (04) :1508-1508

[30] QUANTITATIVE-ANALYSIS OF ANTIBODY LOCALIZATION IN HUMAN METASTATIC COLON CANCER - A PHASE-I STUDY OF MONOCLONAL ANTIBODY-A33 [J].

WELT, S ;

DIVGI, CR ;

REAL, FX ;

YEH, SD ;

GARINCHESA, P ;

FINSTAD, CL ;

SAKAMOTO, J ;

COHEN, A ;

SIGURDSON, ER ;

KEMENY, N ;

CARSWELL, EA ;

OETTGEN, HF ;

OLD, LJ .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (11) :1894-1906

← 1 2 3 4 5 →